EDA2R/TNFRSF27/XEDAR Antibody [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-76710H
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse
Applications
ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
HRP
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Antibody was raised against recombinant human XEDAR.
Reactivity Notes
Mouse reactivity reported in scientific literature (PMID: 26352300).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for EDA2R/TNFRSF27/XEDAR Antibody [HRP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Peptide affinity purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: EDA2R/TNFRSF27/XEDAR
Long Name
Ectodysplasin A2 Receptor
Alternate Names
EDAA2R, TNFRSF27, XEDAR
Gene Symbol
EDA2R
Additional EDA2R/TNFRSF27/XEDAR Products
Product Documents for EDA2R/TNFRSF27/XEDAR Antibody [HRP]
Product Specific Notices for EDA2R/TNFRSF27/XEDAR Antibody [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...